Cipla Tofacitinib Tabletd IP 5 mg Tofajak

About Cipla Tofacitinib Tabletd IP 5 mg Tofajak

Tofacitinib Tablets IP 5 mg (Brand: Tofajak) is a prescription medication manufactured by Cipla Ltd., widely used in the treatment of autoimmune and inflammatory disorders. It belongs to the class of Janus Kinase (JAK) inhibitors, which work by modulating the immune system and reducing inflammation.

Tofajak is commonly prescribed for patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ulcerative Colitis, especially in cases where conventional therapies have shown inadequate response.

Indications / Uses:

• Rheumatoid Arthritis

• Psoriatic Arthritis

• Ulcerative Colitis

• Other autoimmune inflammatory conditions (as prescribed)

Benefits:

• Helps reduce joint pain, swelling, and stiffness

• Controls inflammation at the cellular level

• Improves mobility and quality of life

• Trusted Cipla quality and compliance

Dosage & Administration:

Dosage should be taken strictly as directed by a registered medical practitioner.

Storage Instructions:

• Store in a cool, dry place

• Protect from light and moisture

• Keep out of reach of children

Effective Relief for Autoimmune Disorders

Tofajak delivers targeted immunomodulation for treating rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis in adults. As an advanced oral JAK inhibitor, it helps diminish inflammation, relieve pain, and improve joint or bowel function. Its film-coated tablets ensure patient comfort and compliance, supporting long-term disease management.


Convenient Oral Administration

This medication is taken by mouth, offering a practical alternative to injectable therapies. Supplied in a convenient 30-tablet blister strip, Tofajak simplifies adherence to treatment regimens. Each dose precisely delivers 5 mg of tofacitinib, making daily management straightforward for adult patients.


Strict Prescription and Safety Controls

Tofajak can only be used under the supervision of a registered medical professional. It is essential to consult your doctor before starting, especially if you are pregnant or breastfeeding. The product has been approved by CDSCO for safety and efficacy, but routine monitoring for side effects is strongly advised during therapy.